Advanced Clinical Research, Inc.

Banning, California 92220

0 studies enrolling now · 1 studies all time

What they study most

Mild to Moderate Alzheimer's Disease

Studies at this site

• Efficacy and Safety of 26-Week Treatment of AR1001 in Patients With Mild to Moderate Alzheimer's Disease — Completed